TKPHF News and Press, Takeda Pharmaceutical Co Ltd From 11/27/25

2025-11-27 07:20:44 ET Introduction As the year comes to an end, we must be thankful for the therapies that are in late clinical stages. Most importantly, patients are set to benefit immensely. But nearly every trial candidate has implications beyond just patients. The approval of a...

2025-11-21 08:00:50 ET Introduction Bristol-Myers Squibb ( BMY ) is a company that was blessed with multiple early mega blockbuster therapies: Eliquis, Opdivo, and Revlimid (via Celgene). Sometimes, mega blockbusters are more of a curse than a blessing. They lead to tremendo...

2025-11-14 10:38:47 ET Thesis Teva Pharmaceutical Industries Limited ( TEVA ), founded in 1901 and based in Israel, has developed into one of the world’s leading generics drug companies. They rank closely with Sandoz ( SDZNY ), Viatris ( VTRS ) – formed...

2025-10-31 10:39:51 ET Yes, as always, I'll start with a quote , but today it's from "A Farewell to Arms," by my favorite writer, Ernest Hemingway.... Read the full article on Seeking Alpha For further details see: AbbVie: Why Q3 Confirms Its Immunology Dominance

2025-10-31 04:59:14 ET Takeda Pharmaceutical Company Limited (TAK) Q2 FY2025 Earnings Call October 30, 2025 6:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q2 FY2025 Earnings Call Transcript

2025-10-30 16:16:24 ET Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call October 30, 2025 6:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call Transcript

2025-10-30 03:17:02 ET More on Takeda Pharmaceutical Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules Transcript Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic C...

2025-10-27 14:56:47 ET Read the full article on Seeking Alpha For further details see: Harmony Biosciences: Performing Commercially But Competition Afoot

2025-10-22 13:33:50 ET Takeda Pharmaceutical Company Limited (TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT... Read the full article on Seeking Alpha For further details see: Takeda Pharmaceut...

2025-10-22 01:55:39 ET More on Innovent Biologics, Takeda Pharmaceutical Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually Takeda Pharmaceutical Company Limited (TAK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Taked...